Volume 65, Issue 4, Pages (April 2004)

Slides:

Advertisements

Similar presentations

Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy Francesco Paolo Schena Kidney International Volume 57,

Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Mitchell H. Rosner, W. Kline Bolton Kidney International

Volume 83, Issue 3, Pages (March 2013)

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Stem cells for kidney repair: useful tool for acute renal failure?

Volume 65, Issue 5, Pages (May 2004)

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Demetrios J. Kutsogiannis, R.T.Noel.

Membranous nephropathy: When and how to treat

Continuous renal replacement therapy in the critically ill patient

Volume 80, Issue 10, Pages (November 2011)

Progression of renal failure and hypertensive nephrosclerosis

Section 5: Dialysis Interventions for Treatment of AKI

Francesco Paolo Schena Kidney International

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 70, Pages S21-S25 (December 2006)

Steven J. Chadban, Natalie D. Staplin Kidney International

Volume 65, Issue 1, Pages (January 2004)

Comorbidity and confounding in end-stage renal disease

Volume 70, Issue 11, Pages (December 2006)

The epidemiology of chronic kidney disease

Volume 71, Issue 6, Pages (March 2007)

The calcium–phosphorus in guidelines for CKD-MBD

Saulo Klahr, Jeremiah J. Morrissey Kidney International

Volume 70, Issue 12, Pages (December 2006)

Volume 73, Issue 10, Pages (May 2008)

Volume 59, Issue 4, Pages (April 2001)

Volume 70, Issue 8, Pages (October 2006)

Fructose intake as a risk factor for kidney stone disease

David J. Leehey, MD, Tony Casini, MS, Donald Massey, DO

Volume 76, Issue 6, Pages (September 2009)

Volume 87, Issue 1, Pages (January 2015)

Volume 72, Issue 12, Pages (December 2007)

Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome Masaru Nakayama, MD, Ritsuko Katafuchi, MD, Tetsuro.

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 65, Issue 4, Pages (April 2004)

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Volume 66, Issue 6, Pages (December 2004)

Simvastatin in nephrotic syndrome

Counteracting progression of renal disease: A look into the future

Lynda Anne Szczech, Ira L. Lazar Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Volume 71, Issue 4, Pages (February 2007)

The clinical course of patients with IgG4-related kidney disease

The Danish Renal Biopsy Register

Volume 80, Issue 10, Pages (November 2011)

Volume 58, Issue 1, Pages (July 2000)

Is it the low-protein diet or simply the salt restriction?

Treatment of the primary hyperoxalurias: A new chapter

Volume 64, Issue 4, Pages (October 2003)

Charles A. Herzog Kidney International

Volume 70, Issue 3, Pages (August 2006)

The hypothesis that abnormal BH4 metabolism impairs kidney function

Is complement a target for therapy in renal disease?

Volume 85, Issue 6, Pages (June 2014)

Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular.

Volume 75, Issue 7, Pages (April 2009)

Erratum Kidney International Volume 61, Issue 4, (April 2002)

The changing face of childhood nephrotic syndrome

Membranous nephropathy: recent travels and new roads ahead

Dana V. Rizk, David G. Warnock Kidney International

Volume 70, Issue 10, Pages (November 2006)

Volume 69, Issue 8, Pages (April 2006)

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

Familial phenotype differences in PKD11

Prediction in idiopathic membranous nephropathy

Peggy W. G. du Buf-Vereijken, MD, Amanda J. W. Branten, MD, Jack F. M

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Volume 65, Issue 4, Pages 1400-1407 (April 2004) Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan Hideo Shiiki, Takao Saito, Yoshiharu Nishitani, Tetsuya Mitarai, Noriaki Yorioka, Ashio Yoshimura, Hitoshi Yokoyama, Shinichi Nishi, Yasuhiko Tomino, Kiyoshi Kurokawa, Hideto Sakai, Members and Coworkers of the Research Group on Progressive Renal Diseases in Japan Kidney International Volume 65, Issue 4, Pages 1400-1407 (April 2004) DOI: 10.1111/j.1523-1755.2004.00518.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Overall renal survival for patients with idiopathic membranous nephropathy (IMN). Kidney International 2004 65, 1400-1407DOI: (10.1111/j.1523-1755.2004.00518.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Renal survival rates: Comparison of patients receiving different treatments. Patients in the corticosteroids-alone and corticosteroids + cyclophosphamide groups showed a significant improvement of renal survival rates compared to those in the supportive therapy group, respectively. Kidney International 2004 65, 1400-1407DOI: (10.1111/j.1523-1755.2004.00518.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Comparison of renal survival rates for response to treatment. Patients in complete remission (CR), incomplete remission I (ICR I), and incomplete remission II (ICR II) showed a significant improvement in renal survival rate compared to nonresponders (NR). The difference between CR and ICR II was also significant. *P = 0.004; **P < 0.0001. Kidney International 2004 65, 1400-1407DOI: (10.1111/j.1523-1755.2004.00518.x) Copyright © 2004 International Society of Nephrology Terms and Conditions